How not to run a sin­gle-arm tri­al: EMA high­lights more than a dozen 'bi­as­es' — and ways to mit­i­gate them

The Eu­ro­pean Med­i­cines Agency to­day out­lined some po­ten­tial bi­as­es — and pos­si­ble so­lu­tions — for bio­phar­ma com­pa­nies that wish to sub­mit clin­i­cal da­ta from sin­gle-arm tri­als for …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER